Goldacre
Roche increases data access
February 27, 2013Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche
Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency
You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
GSK announces AllTrials support
February 6, 2013Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre
GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …
Payments register moves closer
January 29, 2013Sales and Marketing Bad pharma, Goldacre, NHS, doctors, pharma
Greater transparency around the payments made by pharma companies to doctors looks to have moved a step closer with a …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
EFPIA rejects ‘indiscriminate’ transparency
November 16, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials
Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …
Goldacre is right – greater honesty is needed
November 7, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose
One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …
NHS to host first ‘hack day’ event
May 22, 2012Medical Communications, Sales and Marketing Goldacre, Gray, London, NHS, hack event
The NHS will host its first ‘hack day’ event this weekend in London, with the aim of sharing software that …
